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Introduction
Radiation therapy uses high
energy rays or particles to kill
cancer cells. Goal of radiation
therapy treatment is to deliver a
dose of radiation precisely to a
tumor, while limiting radiation dose
received by normal, noncancerous
tissues.

External Beam Therapy
• Delivery of radiation to a patient
from a unit such as a linear
accelerator whereby radiation
enters patient from external
surface of the body.
• Patient receives radiation from a
source outside the body that is
focused onto the cancer.
• Used for more advanced Wilms
tumors (Stages III, IV, and V).
(Long, Rollins, & Smith, 2019, p. 432).

Cancer Severity
Stage I: Tumor limited to kidney
and completely resected with no
residual microscopic disease.
Stage II: Tumor grown outside the
kidney, but is excised completely.
Stage III: Residual nonhematogenous spreading of tumor
confined to the abdomen.
Stage IV: Hematogenous
spreading of either lungs, liver,
brain, or bones, or to lymph nodes.
Stage V: Tumor found in both
kidneys at the time of diagnosis.

What is Wilms Tumor?

Imaging Options

poor patient outcomes

• A rare kidney cancer that
primarily affects children.
• Also known as nephroblastoma,
it's the most common cancer of
the kidneys in children.
• Most often affects children ages
3 to 4 (Pater et al., 2020, p. S1).
• Symptoms include swelling &
pain in abdomen, palpable mass
in abdomen, fever, & hematuria
(Pater et al., 2020, p. S1).
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Treatment Options
Stage I: Surgery completed to
remove tumor along with entire
kidney and nearby structures.
Stage II: After surgery, standard
treatment is chemo with actinomycin
D and vincristine.
Stage III: Treatment is usually
surgery if it can be done, followed by
radiation therapy and chemo.
Stage IV: Treatment is usually
surgery if it can be done, followed by
radiation therapy and chemo.
Stage V: Treatment for children with
tumors in both kidneys is unique for
each child, although it typically
includes surgery, chemo, and
radiation therapy at some point.
(American Cancer Society, 2018a&b).

Conclusion
• Image showing urinary system
which includes kidneys, ureters,
bladder & urethra.
• Responsible for removing waste
from the body through urine
(Mayo Clinic, 2017, para. 2).

Contributing Factors
Poor patient outcomes depend on:
• Late presentation
• Malnutrition and drug toxicity
• Limited resources
• Culture and lack of education
• Limited reporting
(Cunningham et al., 2019, p. 49).

“Palpable left-side abdominal mass in
4-year-old girl. Mass arising from left
kidney on sonogram.
a.) Transverse sonographic image
shows mass (arrow) distending the
intrahepatic inferior vena cava,
compatible with tumor thrombus.
b.) Confirmed on staging CT.
Extension of tumor thrombus into
intrahepatic inferior vena cava (arrow)
a safe primary nephrectomy.”
(Servaes, Hoffer, Smith, & Khanna,
2019, p. 1443).

• The current survival in patients
with WT is high (90%).
• Most common sites of recurrence
are lungs (58%) & abdomen
(29%).
• Further studies should be
highlighted on how to use
chemotherapy & radiotherapy
under more accurate risk-stratified
strategies and decrease late
effects of surgery.
• Surgeons must be more focused
on how to maximize preoperative
& postoperative treatment
possibilities for achieving optimal
results of patients with WT
(Wang et al., 2019, p. 3).
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